ÂÜÀòÂÒÂ×

Marc Swikalus joined Samus Therapeutics in April 2018 as the Director of Financial Planning & Analysis and currently serves as Vice President of Finance and Controller. Mr. Swikalus brings over 22 years of finance and accounting experience within the life science, computer software, and public accounting industries. Prior to joining Samus, Mr. Swikalus served as the Manager of Accounting and Reporting at Civitas Therapeutics and Manager of Budgeting and Forecasting at Ziopharm Oncology, Inc. Mr. Swikalus obtained his BS in Accounting from Bentley University and his MBA from Western New England University.